Ferguson Wellman Capital Management, Inc Gsk PLC Transaction History

Ferguson Wellman Capital Management, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$38.11 - $42.99 $414,713 - $467,817	-10,882 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$37.87 - $43.58 $4.74 Million - $5.46 Million	-125,186 Reduced 92.0%	10,882 $444,000
Q1 2020 Apr 21, 2020	BUY	$32.47 - $48.83 $192,417 - $289,366	5,926 Added 4.55%	136,068 $5.16 Million
Q4 2019 Jan 24, 2020	BUY	$42.0 - $48.25 $210,756 - $242,118	5,018 Added 4.01%	130,142 $6.12 Million
Q3 2019 Oct 15, 2019	BUY	$40.46 - $43.52 $174,787 - $188,006	4,320 Added 3.58%	125,124 $5.34 Million
Q2 2019 Jul 16, 2019	BUY	$39.4 - $42.7 $88,216 - $95,605	2,239 Added 1.89%	120,804 $4.84 Million
Q1 2019 Apr 11, 2019	BUY	$38.57 - $42.69 $179,967 - $199,191	4,666 Added 4.1%	118,565 $4.96 Million
Q4 2018 Jan 16, 2019	BUY	$37.8 - $42.69 $4.01 Million - $4.53 Million	106,008 Added 1343.4%	113,899 $4.44 Million
Q1 2018 Apr 09, 2018	BUY	$36.18 - $40.15 $7,236 - $8,030	200 Added 2.6%	7,891 $308,000
Q4 2017 Jan 24, 2018	BUY	$35.34 - $41.9 $3,534 - $4,190	100 Added 1.32%	7,691 $273,000
Q3 2017 Oct 11, 2017	BUY	$39.44 - $41.55 $299,389 - $315,406	7,591	7,591 $308,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.